Similar Papers

Paper Title
Journal
Date
Author
Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: An EORTC Gynecological Cancer Cooperative Group study
J.B Vermorken ... N Colombo
Annals of Oncology | VOL. 12
J.B Vermorken, et. al.J.B Vermorken ... N Colombo
01 Jul 2001
A comparative study of a monoclonal antibody against EGFR (nimotuzumab) used in combination with chemoradiation versus chemoradiation alone in the treatment of locally advanced inoperable squamous cell carcinoma of the head and neck.
Aseem Rai Bhatnagar ... Dharam Pal Singh
Journal of Clinical Oncology | VOL. 30
Aseem Rai Bhatnagar, et. al.Aseem Rai Bhatnagar ... Dharam Pal Singh
20 Oct 2012
Experience of successful use of immunotherapy in treatment of locally advanced inoperable squamous cell carcinoma of the hairy part of the head
B G Pkheshkhova ... M B Pak
MD-Onco | VOL. 3
B G Pkheshkhova, et. al.B G Pkheshkhova ... M B Pak
15 Mar 2023
A comparative study of monoclonal antibody against EGFR (nimotuzumab) used in combination with chemoradiation versus chemoradiation alone in the treatment of locally advanced inoperable squamous cell carcinoma of the head and neck.
Aseem Rai Bhatnagar ... Rameshwaram Sharma
Journal of Clinical Oncology | VOL. 30
Aseem Rai Bhatnagar, et. al.Aseem Rai Bhatnagar ... Rameshwaram Sharma
20 May 2012
View more papers

More From: Gynecologic Oncology

Paper Title
Journal
Date
Author
Serum CA125 levels in the context of ProMisE molecular classification provides pre-operative prognostic information that can direct endometrial cancer management.
Andrea Neilson ... Jessica N Mcalpine
Gynecologic oncology | VOL. 193
Andrea Neilson, et. al.Andrea Neilson ... Jessica N Mcalpine
01 Feb 2025
What happens after menopause? (WHAM): A prospective controlled study of cognition 24months after premenopausal risk-reducing salpingo-oophorectomy.
Pauline M Maki ... Martha Hickey
Gynecologic oncology | VOL. 193
Pauline M Maki, et. al.Pauline M Maki ... Martha Hickey
01 Feb 2025
Added prognostic value of sentinel lymph node mapping in endometrial cancer to molecular subgroups
Franziska Siegenthaler ... Michael D Mueller
Gynecologic Oncology | VOL. 193
Franziska Siegenthaler, et. al.Franziska Siegenthaler ... Michael D Mueller
01 Feb 2025
Barriers to early detection: Insurance denials for breast MRI screening in women with germline BRCA1/2 mutations
S Gordhandas ... E Aviki
Gynecologic Oncology | VOL. 193
S Gordhandas, et. al.S Gordhandas ... E Aviki
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.